AdamsC, AndersonJ, MadvaEN, LaFranceWC, PerezDL: You've made the diagnosis of functional neurological disorder: Now what?. Pract Neurol, 18:323–330, 2018.
2.
ArnstenA, RobbinsT: Neurochemical modulation of prefrontal cortical function in humans and animals. In: Principles of Frontal Lobe Function. Edited by StussD, KnightR.New York, NY, Oxford University Press, 2002.
3.
ArnstenAFT, WangM: Targeting prefrontal cortical systems for drug development: Potential therapies for cognitive disorders. Annu Rev Pharmacol Toxicol, 56:339–360, 2016.
4.
BehrendtR-P: Neuroanatomy of Social Behaviour: An Evolutionary and Psychoanalytic Perspective. London, United Kingdom, Karnac Books Ltd., 2011.
5.
BelkinM, SchwartzT: Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder. Drugs Context, 4:1–5, 2015.
6.
ConnorDF, GrassoDJ, SlivinskyMD, PearsonGS, BangaA: An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol, 23:244–251, 2013.
7.
DibbleED, CohenDJ: Personality development in identical twins: The first decade of life. Psychoanal Study Child, 36:45–70, 1981.
8.
EtkinA, GyurakA, O'HaraR: A neurobiological approach to the cognitive deficits of psychiatric disorders. Dialogues Clin Neurosci, 15:419–429, 2013.
9.
FoxHC, SeoD, TuitK, HansenJ, KimmerlingA, MorganPT, SinhaR: Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: Preliminary findings. J Psychopharmacol, 26:958–972, 2012.
KapelariK, KirchlechnerC, HöglerW, SchweitzerK, VirgoliniI, MoncayoR: Pediatric reference intervals for thyroid hormone levels from birth to adulthood: A retrospective study. BMC Endocr Disord, 8:15, 2008.
12.
KaplanMJ: A psychodynamic perspective on treatment of patients with conversion and other somatoform disorders. Psychodyn Psychiatry, 42:593–615, 2014.
13.
LockwoodJ, DaleyD, TownsendE, SayalK: Impulsivity and self-harm in adolescence: A systematic review. Eur Child Adolesc Psychiatry, 26:387–402, 2017.
14.
MathaiDS, HolstM, RodgmanC, HaileCN, KellerJ, HussainMZ, KostenTR, NewtonTF, VerricoCD: Guanfacine attenuates adverse effects of dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A pilot study. J Neuropsychiatry Clin Neurosci, 30:66–76, 2018.
15.
McAllisterTW, McDonaldBC, FlashmanLA, FerrellRB, TostesonTD, YanofskyNN, GroveMR, SaykinAJ: Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: Altered working memory and BOLD response. Int J Psychophysiol, 82:107–114, 2011.
16.
McKeeSA, PotenzaMN, KoberH, SofuogluM, ArnstenAFT, PicciottoMR, WeinbergerAH, AshareR, SinhaR: A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation. J Psychopharmacol, 29:300–311, 2015.
17.
MeszarosG, HorvathLO, BalazsJ: Self-injury and externalizing pathology: A systematic literature review. BMC Psychiatry, 17:160, 2017.
18.
O'NealMA, BasletG: Treatment for patients with a functional neurological disorder (conversion disorder): An integrated approach. Am J Psychiatry, 175:307–314, 2018.
19.
RiceTR: Commentary: Neural changes associated with treatment outcome in children with externalizing problems. Front Psychiatry, 7:161, 2016.
20.
RiceTR: Commentary: Executive functioning-a key construct for understanding developmental psychopathology or a “catch-all”. term in need of some rethinking? Front Neurosci, 11:130, 2017.
21.
ScahillL, ChappellPB, KimYS, SchultzRT, KatsovichL, ShepherdE, ArnstenAF, CohenDJ, LeckmanJF: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry, 158:1067–1074, 2001.
22.
ScahillL, ErenbergG, BerlinCM, BudmanC, CoffeyBJ, JankovicJ, KiesslingL, KingRA, KurlanR, LangA, MinkJ, MurphyT, ZinnerS, WalkupJ, Tourette Syndrome Association Medical AdvisoryBoard: Practice Committee: Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx, 3:192–206, 2006.
